CTT2274
CTT2274 is a prodrug of MMAE (HY-15162). CTT2274 is composed of a prostate-specific membrane antigen (PSMA)-binding scaffold, a biphenyl motif, a pH-sensitive phosphoramidate linker, and MMAE payload. CTT2274 shows selective binding to PSMA and delivers MMAE. CTT2274 inhibits prostate cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C119H159N17O33P2
- Masse moléculaire:2417.58
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Chemical Information
-
Masse moléculaire 2417.58
-
Formule C119H159N17O33P2
-
SMILES
O[C@@H](C1=CC=CC=C1)[C@H](NC([C@@H]([C@H]([C@@H]2CCCN2C(C[C@H]([C@H]([C@@H](C)CC)N(C([C@H](C(C)C)NC([C@H](C(C)C)N(C(OCC3=CC=C(OC(N(CCN(P(OCC[C@H](NC(C4=CC=C(CN5C6=C(N=N5)C7=C(N(CC8=C6C=CC=C8)C(CCC(N[C@@H](CC9=CC=C(C%10=CC=CC=C%10)C=C9)C(NCCCCCC(N[C@@H](CCC(N[C@@H](CCCOP(N[C@@H](CCC(O)=O)C(O)=O)(O)=O)C(O)=O)=O)C(O)=O)=O)=O)=O)=O)C=CC=C7)C=C4)=O)C(O)=O)(O)=O)C)C)=O)C=C3)=O)C)=O)=O)C)OC)=O)OC)C)=O)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Bomba HN, et al. A Unique Prodrug Targeting the Prostate-Specific Membrane Antigen for the Delivery of Monomethyl Auristatin E. Bioconjug Chem. 2025 Feb 19;36(2):169-178.Bomba HN, et al. A Unique Prodrug Targeting the Prostate-Specific Membrane Antigen for the Delivery of Monomethyl Auristatin E. Bioconjug Chem. 2025 Feb 19;36(2):169-178. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CTT2274 Related Classifications
HY-168913 Related Classifications
Powered by Bioz